# Effect of Benzalkonium Chloride Preserved and Preservative-free Latanoprost Eye Drops on Conjunctival Goblet Cells

> **NCT04957329** · PHASE4 · RECRUITING · sponsor: **Rigshospitalet, Denmark** · enrollment: 28 (estimated)

## Conditions studied

- Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Xalatan
- **DRUG:** Monoprost

## Key facts

- **NCT ID:** NCT04957329
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2023-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04957329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04957329, "Effect of Benzalkonium Chloride Preserved and Preservative-free Latanoprost Eye Drops on Conjunctival Goblet Cells". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04957329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*